Cargando…
Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-α reagents
A third of the world’s population is exposed to Mycobacterium tuberculosis in their lifetime. Over eight million people develop a tuberculosis (TB) illness and 1.3 million people die from the disease every year. Acquired immunity (cytotoxic CD8+ T cells (CBT), Th1 CD4+ helper T cells) macrophages, a...
Autor principal: | Yasui, Kozo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196001/ https://www.ncbi.nlm.nih.gov/pubmed/25317081 http://dx.doi.org/10.1186/1546-0096-12-45 |
Ejemplares similares
-
Biology of IL-27 and its Role in the Host Immunity against Mycobacterium Tuberculosis
por: Abdalla, Abualgasim Elgaili, et al.
Publicado: (2015) -
Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment
por: Benhadou, Farida, et al.
Publicado: (2021) -
TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes
por: Dai, Fang-fang, et al.
Publicado: (2022) -
Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection
por: Li, Wu, et al.
Publicado: (2012) -
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
por: Davuluri, Kusuma Sai, et al.
Publicado: (2023)